Up Next: The House Commerce and Consumer Affairs Committee will hold a hearing on Wednesday, January 17, on HB 1365, which would allow a pharmacist to substitute a biological product for a referenced biological product. PCMA is neutral on the bill but will attend the hearing and monitor the discussion.
If you have any questions, please contact Sam Hallemeier at shallemeier@pcmanet.org.
